Ticker LaunchSPAC · Liquidated
DA32 Life Science Tech Acquisition Corp.
DA32 Life Science Tech Acquisition Corp. is a blank-check company (SPAC) that raised $200M in its initial public offering on Jul 29, 2021, listing on Nasdaq Capital Market. It did not complete a business combination and liquidated around Jul 28, 2023, returning the trust to public shareholders. Co-Founder of BlueStone Venture Partners led the IPO, with Health Catalysts and Allscripts Healthcare Solutions. White & Case advised the SPAC and Kirkland & Ellis advised the underwriters on the IPO.
- Status
- Liquidated
- IPO date
- Jul 29, 2021
- IPO size
- $200M
- IPO exchange
- Nasdaq Capital Market
- IPO underwriters
- Co-Founder of BlueStone Venture Partners, Health Catalysts, Allscripts Healthcare Solutions, Genzyme, CEO of Zymark and President of FMC
- SPAC counsel (IPO)
- White & Case
- Underwriters' counsel (IPO)
- Kirkland & Ellis
More on this SPAC for subscribers
- Trust balance and value per share
- Liquidation deadline and extension history
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Jul 29, 2021
- All filings on EDGAR CIK 1863294
Other SPAC IPOs from 2021
- Software Acquisition Group Inc. IIIJul 30, 2021 · $200M
- Metals Acquisition CorpJul 30, 2021 · $250M
- International Media Acquisition Corp.Jul 29, 2021 · $200M
- Alpha Partners Technology Merger Corp.Jul 29, 2021 · $250M
- Williams Rowland Acquisition Corp.Jul 28, 2021 · $200M
- Alpha Healthcare Acquisition Corp. IIIJul 27, 2021 · $150M